Abametapir Inhibitor

Abametapir, a metalloproteinase inhibitor, is able to target metalloproteinases critical to egg hatching and louse development.

Bowles VM, Hanegraaf S, Ahveninen T.et al.Effect of a New Head Lice treatment, Abametapir Lotion, 0.74%, on Louse Eggs: A Randomized, Double-Blind Study.Glob Pediatr Health. 2019 Feb 22.
Bowles VM, Hanegraaf S, Ahveninen T.et al.Effect of a New Head Lice treatment, Abametapir Lotion, 0.74%, on Louse Eggs: A Randomized, Double-Blind Study.Glob Pediatr Health. 2019 Feb 22.
Bowles, Vernon, M, et al. Clinical studies evaluating abametapir lotion, 0.74%, for the treatment,of head louse infestation[J]. Pediatric dermatology, 2018.
Bowles, Vernon, M, et al. Clinical studies evaluating abametapir lotion, 0.74%, for the treatment,of head louse infestation[J]. Pediatric dermatology, 2018.

Small volumes of Abametapir, inhibitor vial(s) may occasionally become entrapped in the seal of the product vial during shipment and storage. If necessary, briefly centrifuge the vial on a tabletop centrifuge to dislodge any liquid in the container`s cap. Certain products may require to ship with dry ice and additional dry ice fee may apply.

MBS5758354 is an inhibitor targeting Abametapir.